Breast Cancer and Antinuclear Antibodies - Ben Azaiz, Mouna
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

Autoantibody testing must be carried out by a laboratory capable of implementing all the techniques required for detection and identification. All results must be interpreted according to the clinical context, which is why close collaboration between the prescribing physician and the biologist is essential. Indirect immunofluorescence remains the current screening technique for most autoantibodies.The risk of anti-nuclear antibodies in breast cancer patients needs to be thoroughly investigated in a study of 100 hospitalized patients to estimate the strength of the association between breast…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Autoantibody testing must be carried out by a laboratory capable of implementing all the techniques required for detection and identification. All results must be interpreted according to the clinical context, which is why close collaboration between the prescribing physician and the biologist is essential. Indirect immunofluorescence remains the current screening technique for most autoantibodies.The risk of anti-nuclear antibodies in breast cancer patients needs to be thoroughly investigated in a study of 100 hospitalized patients to estimate the strength of the association between breast cancer and antibodies.Characteristic and pathological analyses of patients with positive antinuclear antibodies are not significant, but the antibodies found are very frequent in relation to patient numbers.We're going to complete the follow-up of the patients by increasing their number to fully understand the relationship of the antibodies we found in our results.
Autorenporträt
Ela é a Dra. Ben AZAIZ Mouna. Ela estudou na Faculdade de Medicina de outubro de 1996 a junho de 2001. Obteve seu Diploma de Especialidade em Imunologia em outubro de 2011.- Tornou-se assistente em um hospital universitário em julho de 2012;-Em 2019, foi admitida no concurso de Agrégation;- Defendeu sua tese científica em fevereiro.